SYN-AKE (Dipeptide Diaminobutyroyl Benzylamide Diacetate)
Overview
SYN-AKE is a synthetic dipeptide derivative inspired by the venom peptide waglerin-1 from the Temple viper. It acts as a competitive antagonist at nicotinic acetylcholine receptors on the postsynaptic muscle membrane, thereby reducing muscle contraction and potentially smoothing expression lines.
Mechanism of Action
The compound is marketed as a topical alternative to botulinum toxin, though with substantially lower receptor affinity and clinical effect.
Research Summary & Key Findings
In vitro receptor binding assays have confirmed weak antagonism at muscle-type nicotinic receptors. Small-scale cosmetic trials have suggested modest reductions in forehead and crow's feet wrinkle depth after four weeks of topical application, though blinding and placebo controls are often not rigorously detailed. No studies in peer-reviewed dermatology or pharmacology journals have established standardized clinical efficacy.
Clinical Status
SYN-AKE (Dipeptide Diaminobutyroyl Benzylamide Diacetate) is in the investigational stage. While preclinical and early-phase data exist, it has not received regulatory approval for clinical use in the United States.
Administration Routes
References
Primary literature
- PubMed — "SYN-AKE"
Peer-reviewed literature indexed by the National Library of Medicine.
- ClinicalTrials.gov — "SYN-AKE"
Registered interventional and observational studies, including status and phase.
- PubChem — "SYN-AKE"
Chemical structure, molecular properties, and bioactivity data.
Study-level citations for this compound are being verified against the primary sources before publication. The database queries above return the current indexed literature in the meantime.
Related Peptides in Dermatology
Afamelanotide (Scenesse)
FDA ApprovedA synthetic 13-amino acid analog of alpha-melanocyte-stimulating hormone (alpha-MSH) with a substitution of norleucine a...
View detailsArgireline (Acetyl Hexapeptide-8)
InvestigationalArgireline is a synthetic six amino acid peptide (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2) designed to attenuate neurotransmitter...
View detailsMatrixyl (Palmitoyl Pentapeptide-4)
InvestigationalMatrixyl is a lipopeptide composed of a pentapeptide sequence (Lys-Thr-Thr-Lys-Ser) attached to a palmitic acid moiety t...
View detailsMatrixyl 3000
InvestigationalMatrixyl 3000 is a proprietary combination of two lipopeptides: palmitoyl tripeptide-1 (Pal-GHK) and palmitoyl tetrapept...
View detailsStart Your Consultation
Get an AI-proposed SYN-AKE (Dipeptide Diaminobutyroyl Benzylamide Diacetate) protocol reviewed by a physician in our network.
Start Your ConsultationFind a Pharmacy
Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply SYN-AKE (Dipeptide Diaminobutyroyl Benzylamide Diacetate).
Pharmacy DirectoryJoin the Association
Access exclusive peptide protocols, provider resources, and community support.
List Your PracticeDisclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol. See our editorial policy for how this content is produced and reviewed.